IQVIA (IQV) P/E (2013 - 2026)
IQVIA (IQV) P/E from May 9, 2013 to Jun 3, 2026. The TTM IQVIA (IQV) P/E is 22.25. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of IQVIA (IQV)
| Year | P/E | Change |
|---|---|---|
| 2026 | 22.25 | -21.34% |
| 2025 | 28.29 | +9.72% |
| 2024 | 25.78 | -32.45% |
| 2023 | 38.16 | +16.98% |
| 2022 | 32.62 | -41.56% |
| 2021 | 55.82 | -54.56% |
| 2020 | 122.86 | -22.35% |
| 2019 | 158.23 | +79.47% |
| 2018 | 88.17 | -86.96% |
| 2017 | 675.94 | +2858.77% |
| 2016 | 22.85 | +5.23% |
| 2015 | 21.71 | +4.69% |
| 2014 | 20.74 | -19.59% |
| 2013 | 25.79 | N/A |
Comparison IQVIA (IQV) P/E with competitors
IQVIA (IQV) P/E is 22.25.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -96.50% |
| MBAI | CheckCap Ltd | 2.88 | -87.04% |
| FONR | Fonar Corp | 15.41 | -30.72% |
| QGEN | Qiagen NV | 17.55 | -21.13% |
| DGX | Quest Diagnostics Inc | 21.62 | -2.83% |
| LH | Laboratory Corp Of America Holdings | 22.66 | +1.86% |
| A | Agilent Technologies Inc | 25.45 | +14.39% |
| MEDP | Medpace Holdings Inc | 26.32 | +18.32% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | +20.78% |
| MTD | Mettler-Toledo International Inc | 26.96 | +21.18% |
| DHR | Danaher Corp | 33.26 | +49.48% |
| ILMN | Illumina Inc | 34.97 | +57.19% |
| ICLR | Icon Plc | 39.55 | +77.74% |
| IDXX | Idexx Laboratories Inc | 40.14 | +80.40% |
| VCYT | Veracyte Inc | 40.15 | +80.48% |
| RVTY | Revvity Inc | 45.79 | +105.82% |
| SHC | Sotera Health Company | 63.43 | +185.10% |
| WAT | Waters Corp | 93.81 | +321.64% |